Raven-Symoné recalled having her first breast reduction when she was just 15 years old. While speaking on her podcast Tea ...

Raven-Symoné opens up during a recent episode of her podcast Tea Time with Raven & Miranda about her experience with breast reduction surgery at the age of 15.

Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

A review article published by Cell Press in Trends in Cancer discusses how artificial intelligence (AI) is influencing the ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

While speaking on her podcast Tea Time with Raven & Miranda, which she co-hosts with wife Miranda Pearman-Maday, the Disney ...

In a new press note statement shared on social media, Manoj Manchu addresses viral video of him creating chaos outside Mohan Babu’s residence.

BriaCell reports influx of cancer fighting CD8+ "killer” T cell into metastatic breast cancer tumors and lymph organs turning ...

This week, the Henry B. Gonzalez Convention Center is where leading doctors from all over have gathered to share research and ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

Analyst Emily Bodnar of H.C. Wainwright reiterated a Buy rating on Atossa Therapeutics (ATOS – Research Report), retaining the price target of ...